Marrow fatty acids in osteoporosis: metabolic insights, emerging therapeutic targets
Journal of Bone and Mineral Metabolism · 2026-09 · 44 (5) · 567-580
DOI: 10.1007/s00774-026-01737-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Bone and Mineral Metabolism, online erschienen am 15.06.2026. Verfasst von Mengyao Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine…. Hauptthemen laut MEDLINE: Osteoporosis, Fatty Acids, Bone Marrow, Adipose Tissue. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
PURPOSE: This review examines the role of marrow adipose tissue fatty acid composition in skeletal homeostasis, focusing on osteoporosis. To avoid conceptual confusion, we define evidence tiers: human studies assessing endogenous marrow lipid profiles; mechanistic studies applying exogenous fatty acids in vitro and in vivo; indirect MRI-based surrogates of marrow fat quantity; and direct ex vivo measurements of fatty acid composition via GC-MS, LC-MS, and lipidomics. We also clarify the distinction between marrow fat quantity and fatty acid quality. RESULT: Human data reveal disease-, age-, and site-related alterations in marrow lipid saturation and unsaturation; however, findings vary by skeletal site, marrow compartment, fracture status, analytical platform, and study population. Experimental evidence demonstrates that saturated fatty acids (e.g., palmitic acid) induce lipotoxicity and osteoblast dysfunction, whereas unsaturated fatty acids (e.g., oleic acid and n-3 polyunsaturated fatty acids) exert protective effects via modulation of mesenchymal stem cell differentiation, osteoclastogenesis, ferroptosis, autophagy, and mitochondrial metabolism. Collectively, current evidence supports an association between marrow fatty acid biology and osteoporotic bone loss. CONCLUSION: Causal, diagnostic, and therapeutic implications remain preliminary. This review's main contribution is a fatty-acid-centered framework that integrates evidence tiers, molecular categories, and skeletal-site heterogeneity, guiding future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Rd., Shanghai, 200437, China.
- Department of Radiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Rd., Shanghai, 200437, China. guanwu.li@shutcm.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, M., Miao, Z., Xu, R., Luo, P., & Li, G. (2026). Marrow fatty acids in osteoporosis: metabolic insights, emerging therapeutic targets. Journal of Bone and Mineral Metabolism, 44(5), 567-580. https://doi.org/10.1007/s00774-026-01737-9
Vancouver
Guo M, Miao Z, Xu R, Luo P, Li G. Marrow fatty acids in osteoporosis: metabolic insights, emerging therapeutic targets. Journal of Bone and Mineral Metabolism. 2026;44(5):567-580. doi:10.1007/s00774-026-01737-9
BibTeX
@article{Guo2026,
author = {Guo, Mengyao and Miao, Zeyang and Xu, Run and Luo, Peng and Li, Guanwu},
title = {Marrow fatty acids in osteoporosis: metabolic insights, emerging therapeutic targets},
journal = {Journal of Bone and Mineral Metabolism},
year = {2026},
volume = {44},
number = {5},
pages = {567--580},
doi = {10.1007/s00774-026-01737-9}
}
EUVIMED